Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News
Sarepta Advances SRP-1003 for DM1 Triggering $100 Million Milestone Payment to Arrowhead

Safety review leading to dose escalation and achievement of first predetermined enrollment target in Phase 1/2 study of SRP-1003 for DM1 triggers $100 ...

August 14, 2025 | Thursday | News
Amalgam Secures $20M Credit Investment from Catalio Capital to Accelerate Medical-Grade AI Expansion

 announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare com...

August 13, 2025 | Wednesday | News
Fosun Pharma Grants Global Rights (Ex-China) for Innovative Respiratory Drug XH-S004 to Expedition Therapeutics

Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics ...

August 12, 2025 | Tuesday | News
Sartorius and Nanotein Forge Strategic Alliance to Advance Immune Cell Manufacturing

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement...

August 12, 2025 | Tuesday | News
Akeso Doses First Patient in Phase III Trial of Ivonescimab for Limited-Stage Small Cell Lung Cancer

Akeso, Inc.announced that the first patient has been dosed in its multicenter, randomized, double-blind Phase III study (AK112-311/HARMONi-9), evaluating...

August 11, 2025 | Monday | News
Junshi Biosciences’ sNDA for Toripalimab Plus Disitamab Vedotin in HER2-Expressing Urothelial Carcinoma Accepted by China’s NMPA

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to th...

August 11, 2025 | Monday | News
Exact Sciences Secures Exclusive U.S. Rights to Freenome’s Blood-Based Colorectal Cancer Screening Tests

Exact Sciences acquires exclusive rights to current and future versions of Freenome’s blood-based colorectal cancer screening tests Freenome sub...

August 07, 2025 | Thursday | News
Cytiva and Culture Biosciences Expand Global Collaboration to Advance Scalable Digital Bioprocessing

  Culture Biosciences, an expert in cloud-connected bioreactor technology, and Cytiva, a Danaher company and a leader in the life sciences industry, ...

August 07, 2025 | Thursday | News
Repligen and Novasign Forge Strategic Partnership to Advance AI-Driven Bioprocessing

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, announced Novasign and Repligen have entered ...

August 05, 2025 | Tuesday | News
Bristol Myers Squibb’s Breyanzi Granted FDA Priority Review for Relapsed or Refractory Marginal Zone Lymphoma

Breyanzi has the potential to be the first and only CAR T cell therapy approved for MZL, addressing a high unmet need Application based on results fro...

August 05, 2025 | Tuesday | News
WuXi XDC Secures GMP Release of DP3 Facility in Wuxi, Doubling China-Based Bioconjugate Drug Product Capacity

WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announ...

August 05, 2025 | Tuesday | News
Cytiva’s Ludovic Brellier on Future-Ready Biomanufacturing with the ÄKTA readyflux TFF System 500

As advanced modalities like mRNA and viral vectors reshape the biomanufacturing landscape, Cytiva is scaling innovation to meet evolving demands. In this e...

August 05, 2025 | Tuesday | Interaction
MGI and Lincoln University Harness Genomics to Cultivate a Greener Future for New Zealand Viticulture

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, has joined efforts with...

August 04, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close